GSK cancer, HIV drug sales lift 2025 outlook in boost to shares – Reuters

Written by

admin

in

  1. GSK cancer, HIV drug sales lift 2025 outlook in boost to shares  Reuters
  2. GSK Raises Sales, Profit Outlook on Drugs for Immunology and HIV  Bloomberg.com
  3. GSK delivers strong Q3 performance and upgrades 2025 guidance  GSK
  4. GSK raises 2025 sales forecast after strong growth in specialty medicines  Yahoo Finance
  5. GSK plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025  MarketScreener

Continue Reading

More posts